In vivo imaging of translocator protein 18 kDa (TSPO) has received significant attention as potential biomarker of microglia activation. Several radioligands have been designed with improved properties. Our group recently developed an 18 F-labeled TSPO ligand, [ 18 F]-FEPPA, and confirmed its reliability with a 2-tissue compartment model. Here, we extended, in a group of healthy subjects, its suitability for use in voxel-based analysis with the newly proposed graphical analysis approach, Relative-Equilibrium-Gjedde-Patlak (REGP) plot. The REGP plot successfully replicated the total distribution volumes estimated by the 2-tissue compartment model. We also showed its proof-of-concept in a patient with possible meningioma showing increased [
INTRODUCTION
Activated microglia has a pivotal role in neuroinflammation and abundantly expresses a protein in their mitochondria called the translocator protein 18 kDa (TSPO).
1,2 Increased TSPO expression has been shown in different brain diseases such as cerebral ischemia, HIV, encephalitis, Alzheimer's disease, multiple sclerosis, and stroke. 3 To date, there have been a few attempts to use positron emission tomography (PET) to assess the level of microglial activation. First, [ 11 C]-PK11195 has been used to quantify TPSO expression. 4 However, this radiotracer had several limitations including high nonspecific binding, low brain penetration, high plasma protein binding, and a difficult preparation. 4 7) which, while it has overcome some of the previous limitations associated with older tracers, being an 18 Flabeled radiotracer (cf., [ 18 F]-DPA714) it has the advantage of wider distribution to imaging sites distant from the production location particularly useful for larger clinical application.
Recently, Rusjan et al 8 showed that the 2-tissue compartment model-estimated total distribution volume (V T ) is the most reliable outcome for [
18 F]-FEPPA quantification. However, because of the heavy computation and high susceptibility to noise, full kinetic modeling is limited to region-of-interest (ROI) analyses where ROIs must be predefined with specific hypothesis. Thus, it would be important to validate a method to estimate V T in voxel-wise manner which could be useful especially for clinical applications, e.g., where only a small brain region may be affected or no a priori hypothesis exists.
In the absence of a reference region (i.e., brain area that expresses negligible binding 9 ), graphical approaches may be the only solution to estimate voxel-wise V T . The Logan plot 10 is the most widely used graphical analysis that estimates V T , but it underestimates V T in the presence of noise, 11 and as it requires the tracer kinetics to reach its equilibrium, it may not be suitable for voxel-wise calculation for [ 12 recently proposed the RelativeEquilibrium-Gjedde-Patlak (REGP) method for reliable estimation of voxel-wise V T for radioligands that reach equilibrium slowly, i.e., it does not require the tracer kinetics to reach its equilibrium. Mathematically, the total distribution volumes estimated by the Logan (DV L ) and REGP plot (DV REGP ) are the same if, and only if, the noise in the tissue tracer kinetics is negligible. 12 In the present study, we have validated the use of the REGP method for [
18 F]-FEPPA PET in a group of healthy subjects and visualized its proof-of-concept in a patient who had a possible meningioma. Various forms of brain tumors, including meningioma, have been reported to be associated with increased TSPO expression. 13, 14 
MATERIALS AND METHODS Subjects
Fifteen healthy subjects (age 58.9±2.56, mean±s.e.) and one patient with Parkinson's disease (PD) underwent an [
18 F]-FEPPA PET and magnetic resonance imaging scan. The PD patient (female, 68-year-old) had taken part in an on-going [
18 F]-FEPPA PET study but was excluded because of this incidental finding (i.e., possible meningioma). All subjects provided written informed consent after all procedures were fully explained, and were approved by the Center for Addiction and Mental Health Ethics Review Board. The ROI analysis of the healthy subjects was published elsewhere. 8 
Radiochemistry Details of the [
18 F]-FEPPA synthesis have been described elsewhere. 7 It is reliably and quickly labeled with [ 18 F] by nucleophilic displacement of a tosylate leaving group in a fast one-step reaction, yielding a sterile, pyrogen-free product after purification and formulation. 3.22 ). An automatic blood sampling system (ABSS, Model #PBS-101 from Veenstra Instruments, Joure, The Netherlands) was used to measure arterial blood radioactivity levels continuously at a rate of 2.5 mL/min for the first 22.5 minutes. Manual blood samples were obtained at 2.5, 7, 12, 15, 30, 45, 60, 90, and 120 minutes. These samples were used to determine the temporal evolution of the ratio of radioactivity in whole blood to radioactivity in plasma, and the amount of unmetabolized radioligand in plasma needed to create the input function for the kinetic analysis. 8 The scan duration was 125 minutes after the injection of [ 18 F]-FEPPA. The images were reconstructed into 34 time frames. Frames were acquired as followed: 1 frame of variable length, 5 Â 30, 1 Â 45, 2 Â 60, 1 Â 90, 1 Â 120, 1 Â 210, and 22 Â 300 seconds. The PET images were obtained using 3D HRRT brain tomography (CPS/Siemens, Knoxville, TN, USA), which measures radioactivity in 207 slices with an interslice distance of 1.22 mm. All PET images were corrected for attenuation using a single photon point source, 137 Cs (T50 ¼ 30.2 years, Eg ¼ 662 keV) and were reconstructed by filtered back projection algorithm, with a HANN filter at Nyquist cutoff frequency.
Region of Interest-and Voxel-Based Analyses
For the anatomic delineation of ROIs, a brain magnetic resonance image was acquired for each subject. 2D axial proton density magnetic resonance images were acquired with a General Electric (Milwaukee, WI, USA) Signa 1.5T magnetic resonance image scanner (slice thickness
generated using the in-house software, ROMI (ref. 15) . Briefly, ROMI (CAMH, Toronto, Ontario, Canada) fits a standard template of 29 ROIs to an individual highresolution proton density magnetic resonance image scan based on the probability of gray matter, white matter, and cerebrospinal fluid. 15 For the detailed description of the ROIs, see ref. 15 . The individual magnetic resonance image with ROIs properly superimposed is then coregistered to the summed [ 18 F]-FEPPA PET image using a mutual information algorithm to generate the time activity curves from each ROI. Time activity curves and metabolite-corrected plasma input function were used to estimate the V T , DV L , and DV REGP using a 2-tissue compartment model, 8 Logan plot, 10 and REGP plot, 12 respectively. V T was considered reliable only if its coefficient of variation (COV) was o15% (ref. 8) . In addition, DV L and DV REGP were also calculated in voxel-by-voxel basis. 10, 12 The voxel-wise DV L and DV REGP were averaged within each ROI for comparisons with V T estimated by full kinetic analysis results.
To examine if the noise was in fact the source of underestimation in the voxel-based analysis using Logan plot, 11 the voxel-based Logan analysis and regression analysis were repeated with smoothed dynamic PET images (full width at half maximum ¼ (8, 8, 8 mm) and (16, 16, 16 mm) ).
The DV REGP map of the PD patient with meningioma was coregistered with the anatomic magnetic resonance imaging then transformed to Montreal Neurological Institute space for visualization. For this patient, binding potential of [ which is the 'gold standard' for [
18 F]-FEPPA PET quantification. 8 The r 2 40.9 (i.e., 490% of variance is explained by regression model) is considered for reliable estimation of V T . The regression coefficients were also tested as to whether they are significantly different from reference line of y ¼ x (i.e., b 0 ¼ 0 and b 1 ¼ 1) with a one-sample t-test. Figure 1A ). In contrast, as also showed by Zhou et al., 12 DV REGP reliably estimated both the slope and intercept of the regression Figure 1B Figure 1D ).
RESULTS

In
The underestimation of V T by DV L was improved when the dynamic PET images were smoothed with full width at half maximum
368, Po0.001). However, r 2 was slightly decreased as bigger smoothing kernel was used (full width at half maximum ¼ 16 mm,
The PD patient ( Figure 2 ) was excluded from our on-going research study in PD patients because of an incidental finding of possible meningioma in the left frontal lobe. A full kinetic analysis with input function of the ROI showed that the tumor (left frontal) presented a V T of 25.1 mL/cm 3 (%COV ¼ 7%), which was three times higher than the contralateral, right frontal side V T ¼ 7.6 mL/cm 3 (%COV ¼ 3.7).
DISCUSSION
We extended the suitability of [ 18 F]-FEPPA PET for use in voxelbased analysis with the newly proposed graphical analysis approach, i.e., REGP plot. 12 The REGP plot successfully replicated the total distribution volumes estimated by the 2-tissue compartment model. The underestimation of slope and r 2 of regression in the voxel-based Logan plot analysis was improved when the dynamic PET image was smoothed, which indicates that the noise in fact was an important source of error. Nevertheless, the highest r 2 of regression was achieved when voxel-based REGP method was used without smoothing (r 2 ¼ 0.932). We also showed its proof-of-concept in a patient with possible meningioma showing increased [
18 F]-FEPPA total distribution volume. Therefore, voxel-based analysis of [ 18 F]-FEPPA PET may be reliably used for explorative research studies that aim to probe microglia activation in vivo.
In the absence of a blocking experiment (as no TSPO drug is approved for human use), it is not possible to know with certainty how much of this binding is specific and how much is free or nonspecific. Moreover, the shape of the TACs is difficult to compare because the delivery in the tumor is different than in regular tissue; K 1 in the tumor ROI was double than that in the right frontal (0.27 (COV ¼ 5%) versus 0.15 (COV ¼ 3%) mL/cm 3 per minute), and there is no evidence to assume that the distribution volumes of the free and nonspecific compartment are the same in the tumor and the right frontal side. However, relying in the best fitting solution for the full kinetic analysis, the tumor presents a binding potential of 9.9 (COV ¼ 9%) which is 57% higher than the contralateral, right frontal binding potential ¼ 6.3 (COV ¼ 8%). Based on the previous reports that TSPO expression is increased in meningioma 13, 14 and increased binding of [ 18 F]-FEPPA in the brain region with abundant TSPO expression in rats, 7 our results support the utility of [
18 F]-FEPPA PET as a valid probe for TSPO in vivo.
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